Medtronic PLC
MDT: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$813.00 | Rrgdnc | Vvvsxrxx |
Medtronic Earnings: Pockets of Strength Supported Solid Growth in Fiscal Third Quarter
Wide-moat Medtronic delivered solid fiscal third-quarter results, and with the firm running slightly ahead of our projections on the top line, we’ve adjusted our revenue assumptions upward incrementally for the full year. However, this wasn’t enough to materially move our valuation, and we’re leaving our fair value estimate unchanged.